header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

A SINGLE-CENTRE EXPERIENCE OF THE MODULAR RAIL SYSTEM

The British Limb Reconstruction Society (BLRS) Annual Meeting 2022, Brighton, England, 24–25 March 2022.



Abstract

Introduction

Numerous fixation modalities can be used for various indications, including deformity correction, trauma, infection, and non-union. The Modular Rail System (MRS) is a well-tolerated apparatus that is a viable option for patients who do not want a circular frame or for whom internal fixation is not appropriate due to poor soft tissues/co-morbidities. This case series evaluates the outcomes of the use of the MRS in our centre.

Materials and Methods

Cases were identified from a prospectively gathered database. Data were collected including indication for treatment, frame duration, complications and treatment outcome. Eighteen eligible cases were identified (mean age 26, range 8–71). The MRS was sited in the femur in 14 cases, the tibia in three and the fibula in one. In nine cases, a circular frame was sited on the tibia below a femoral MRS. Frames were removed at an average of 20 weeks (range 7–31).

Results

Eight complications occurred in six patients including fracture following removal (2), premature union (2), deep infection (1), scar complications (1), pin exchange (1) and non-union (1). 17/18 patients achieved their treatment goal and a satisfactory clinical outcome.

Conclusions

We have demonstrated the use of the MRS in both trauma and elective practice and have found it to be well tolerated in our cohort of patients, particularly the paediatric and elderly populations. This case series demonstrates that, with the correct patient selection, the MRS is a versatile adjunct for use in limb reconstruction cases.